The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A

Anderson, 1998, Effect of androgen administration during puberty on hepatic CYP2C11, CYP3A, and CYP2A1 expression in adult female rats, Drug Metab. Dispos., 26, 1031 Bensoussan, 1995, Particular ability of cytochromes P450 3A to form inhibitory P450–iron–metabolite complexes upon metabolic oxidation of aminodrugs, Biochem. Pharmacol., 49, 591, 10.1016/0006-2952(94)00477-4 Brøsen, 1993, Fluvoxamine is a potent inhibitor of cytochrome P4501A2, Biochem. Pharmacol., 45, 1211, 10.1016/0006-2952(93)90272-X Burk, 2004, Cytochrome P450 3A and their regulation, Naunyn-Schmiedeberg's Arch. Pharmacol., 369, 105, 10.1007/s00210-003-0815-3 Crewe, 1992, The effect of selective re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes, Br. J. Clin. Pharmacol., 34, 262, 10.1111/j.1365-2125.1992.tb04134.x Dahl, 1997, In vitro and in vitro studies on the disposition of mirtazapine in humans, Clin. Drug Investig., 13, 37, 10.2165/00044011-199713010-00005 Daniel, 1992, Alteration of cytochrome P-450 by prolonged administration of imipramine and/or lithium to rats, Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 234, 10.1007/BF00166970 Daniel, 1981, Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages, Naunyn-Schmiedeberg's Arch. Pharmacol., 317, 209, 10.1007/BF00503818 Daniel, 1999, The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vitro and in vitro studies, Exp. Toxic. Pathol., 51, 309, 10.1016/S0940-2993(99)80012-8 Daniel, 1999, The influence of selective serotonin reuptake inhibitors on the plasma and brain pharmacokinetics of the simplest phenothiazine neuroleptic promazine in the rat, Eur. Neuropsychopharmacol., 9, 337, 10.1016/S0924-977X(99)00006-1 Daniel, 2000, Pharmacokinetics and metabolism of thioridazine during co-administration of tricyclic antidepressants, Br. J. Pharmacol., 131, 287, 10.1038/sj.bjp.0703540 Daniel, 2001, The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat, J. Pharm. Pharmacol., 53, 449, 10.1211/0022357011775749 Daniel, 2002, Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants, J. Pharm. Pharmacol., 54, 1545, 10.1211/002235702162 Debri, 1995, Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues, Biochem. Pharmacol., 50, 2047, 10.1016/0006-2952(95)02107-8 Gibson, 2002, Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man, Xenobiotica, 32, 165, 10.1080/00498250110102674 Hall, 2003, Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine, J. Clin. Psychopharmacol., 23, 349, 10.1097/01.jcp.0000085407.08426.e1 Honkakoski, 2000, Regulation of cytochrome P450 (CYP) genes by nuclear receptors, Biochem. J., 347, 321, 10.1042/0264-6021:3470321 Honkakoski, 2001, A novel drug-regulated gene expression system based on the nuclear receptor constitutive androstane receptor (CAR), Pharmacol. Res., 18, 146, 10.1023/A:1011068015301 Jeppesen, 1996, Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine, Eur. J. Clin. Pharmacol., 51, 73, 10.1007/s002280050163 Jus, 1978, Pharmacokinetic interaction between amitriptyline and neuroleptics, Neuropsychobiology, 4, 305, 10.1159/000117644 Komori, 1994, A major glucocorticoid-inducible P450 in rat liver is not P450 3A1, J. Biochem. (Tokyo), 116, 114, 10.1093/oxfordjournals.jbchem.a124482 Liddle, 1998, Separate and interactive regulation of cytochrome P450 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes, J. Clin. Endocrinol. Metab., 83, 2411, 10.1210/jc.83.7.2411 Loga, 1981, Interaction of chloropromazine and nortriptyline in patients with schizophrenia, Clin. Pharmacokinet., 6, 454, 10.2165/00003088-198106060-00003 Masubuchi, 1995, Inhibition and induction of cytochrome P450 isoenzymes after repetitive administration of imipramine in rats, Drug Metab. Dispos., 23, 999 McNeil, 1996, Inhibition of microsomal cytochromes P450 in rat liver by the tricycle antidepressant drug desipramine and its primary oxidized metabolites, Biochem. Pharmacol., 51, 15, 10.1016/0006-2952(95)02105-1 Murray, 1992, Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants, Biochem. Pharmacol., 43, 2065, 10.1016/0006-2952(92)90163-D Murray, 2003, Mechanism-based inhibition of CYP activities in rat liver by fluoxetine and structurally similar alkylamines, Xenobiotica, 33, 973, 10.1080/00498250310001602748 Pascussi, 2000, Dexamethasone induces pregnane X receptor and retinoid X receptor-α expression in human hepatocytes: synergistic increaseof CYP3A4 induction by pregnane X receptor, Mol. Pharmacol., 58, 361, 10.1124/mol.58.2.361 Pascussi, 2000, Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation, Mol. Pharmacol., 58, 1441, 10.1124/mol.58.6.1441 Pascussi, 2000, Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes, Biochem. Biophys. Res. Commun., 274, 707, 10.1006/bbrc.2000.3219 Pascussi, 2003, The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors, Biochim. Biophys. Acta., 1619, 243, 10.1016/S0304-4165(02)00483-X Preskorn, 1997, Clinically relevant pharmacology of selective serotonin reuptake inhibitors, Clin. Pharmacokinet., 32, 1, 10.2165/00003088-199700321-00003 Quatrochi, 2001, CYP3A regulation: from pharmacology to nuclear receptors, Drug Metab. Dispos., 29, 615 Ring, 1995, Effects of fluoxetine, sertraline and desmethylsertraline on human CYP3A catalyzed 1′-hydroxy midazolam formation in vitro, J. Pharmacol. Exp. Ther., 275, 1131 Schrag, 2001, Covalent alteration of the CYP3A4 active site: evidence for multiple substrate binding domains, Arch. Biochem. Biophys., 391, 49, 10.1006/abbi.2001.2401 Shin, 2002, Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoin, Drug Metab. Dispos., 30, 1102, 10.1124/dmd.30.10.1102 Skjelbo, 1992, Inhibitors of imipramine metabolism by human liver microsomes, Br. J. Clin. Pharmacol., 34, 256, 10.1111/j.1365-2125.1992.tb04133.x Sonderfan, 1987, Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450, Arch. Biochem. Biophys., 255, 27, 10.1016/0003-9861(87)90291-8 Sproule, 1997, Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence, Clin. Pharmacokinet., 33, 454, 10.2165/00003088-199733060-00004 Sunman, 2004, Kupffer cell-mediated IL-2 suppression of CYP3A activity in human hepatocytes, Drug Metab. Dispos., 32, 359, 10.1124/dmd.32.3.359 Syrek, 1997, Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants, Pol. J. Pharmacol., 49, 453 von Moltke, 1996, Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents, J. Clin. Pharmacol., 36, 783, 10.1002/j.1552-4604.1996.tb04251.x von Moltke, 1999, Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions, Psychopharmacology, 145, 113, 10.1007/s002130051039 Wang, 1996, cDNA cloning of a novel CYP3A from rat brain, Biochem. Biophys. Res. Commun., 221, 157, 10.1006/bbrc.1996.0562 Wang, 2000, Human cytochrome P-450 3A4: in vitro drug–drug interaction patterns are substrate-dependent, Drug Metab. Dispos., 28, 360 Warrington, 1992, Clinical implications of the pharmacology of serotonin reuptake inhibitors, Int. Clin. Psychopharmacol., 7, 13, 10.1097/00004850-199210002-00004 Watkins, 1992, Drug metabolism by cytochrome P450 in the liver and small bowel, Gastroenterol. Clin. North Am., 21, 511, 10.1016/S0889-8553(21)00046-7 Waxman, 1995, Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate, Mol. Pharmacol., 48, 790 Wójcikowski, 2002, Thioridazine–fluoxetine interaction at the level of the distribution process in vivo, Pol. J. Pharmacol., 54, 647 Zhang, 1999, Rat pregnane X receptor: molecular cloning, tissue distribution and xenobiotic regulation, Arch. Biochem. Biophys., 368, 14, 10.1006/abbi.1999.1307 Zhao, 1997, The in vitro hepatic metabolism of quinidine in mice, rats and dogs: comparison with human liver microsomes, J. Pharmacol. Exp. Ther., 283, 1168